OrsoBio
Pre-clinicalOrsoBio develops novel therapies for severe metabolic diseases including liver diseases and lipodystrophy.
Founded
2020
Focus
Small Molecules
About
OrsoBio develops novel therapies for severe metabolic diseases including liver diseases and lipodystrophy.
Funding History
2Total raised: $70M
Series A$60MSamsara BioCapitalOct 15, 2022
Seed$10MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationPalo Alto, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile